Scientists track mystery Drug's journey through healthy volunteers
NCT ID NCT07336758
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study in 8 healthy men aims to understand how the experimental drug BI 1584862 is absorbed, broken down, and eliminated from the body. Participants take a single oral dose with a radioactive tracer and a tiny intravenous dose with a stable isotope. Researchers measure the drug and its byproducts in blood, urine, and stool to learn how it behaves.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICON-Groningen-62040
Groningen, 9728 NZ, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Does injection location matter for a new Weight-Loss drug? a trial investigates
- Which medical adhesive stays put longest without itching? a head-to-head test in healthy women.
- Avocado at breakfast: a secret weapon for blood sugar and fullness?
- New eye drop aims to tame ocular pain in early trial
- Could a formula closer to breast milk boost baby development?
- Could a daily probiotic help you feel fuller and eat less?